Anticancer-Related Activity |
3′-OHG |
Antiproliferative activity toward T47D tumorigenic breast epithelial cells; |
[52,53] |
|
8-OHD |
Increases life span against S180 bearing mice; |
[43] |
Suppression of MDR in Caco-2 colon adenocarcinoma cells; |
[58] |
|
8-OHG |
Antimutagenesis activity; |
[36] |
Antiproliferative activity toward HL-60 promyelocytic leukemia cells; |
[35] |
|
6-OHD |
Suppression of HCT-116 colon cancer cell proliferation in vitro and in vivo; |
[54] |
|
3′-OHD |
Suppression of EGF receptor-positive skin cancer cell proliferation in vitro and in vivo; |
[55,56] |
Suppression of MDR transporters; |
[57] |
|
Antimelanogenesis- Related Activity |
6-OHD |
Competitive tyrosinase inhibitor; |
[60] |
|
8-OHD |
Irreversible tyrosinase inhibitor; |
[61,62] |
Antimelanogenesis activity in human volunteers; |
[63] |
|
8-OHG |
Irreversible tyrosinase inhibitor; |
[61,62] |
|
3′-OHD |
Antimelanogenesis activity in human skin equivalents; |
[64,65] |
Potent autophage inducer; |
[67] |
|
Other Bioactivities |
3′-OHG |
HIV-1 integrase inhibitor; |
[25] |
Antiinflammatory activity; |
[68] |
Hepatoprotective activity; |
[24] |
|
6-OHG |
Hepatoprotective activity; |
[46] |
|
8-OHD |
Aldose reductase inhibitor; |
[69] |
|
6-OHD |
Suppression on adipogenesis of 3T3-L1 preadipocytes; |
[70] |
Promoting differentiation of 3T3-L1 preadipocytes; |
[71] |
Antitrypanosomal activity |
[72] |
|
3′-OHD |
Antitrypanosomal activity; |
[72,73] |
Improving atopic dermatitis symptoms; |
[74] |